col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


73 Results       Page 1

 [1] 
Termedia Sp. z.o.o.: Archives of Medical Science
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―06 Mortality analysis of patients with acute coronary syndrome receiving comprehensive cardiac care (KOS-Zawał) during the COVID-19 pandemic period Grzegorz Kubielas, Dorota Diakowska, Michał Czapla, Catherine Ross, Przemysław Mitkowski, Izabella Uchmanowicz
2 [GO] 2024―May―29 Comparison of the effectiveness of the helmet interface using flow meters versus the mechanical ventilator for non-invasive ventilation in patients with coronavirus disease 2019. Controlled and randomized clinical trial Fernanda dos Reis Ferreira, João Carlos Ferrari Correa, Eduardo Storopoli, Diego Restivo Faria, Karina Cassaro, Natália Feitosa da Hora, et al. (+5)
3 [GO] 2024―Apr―23 Factors affecting pregnant women’s feelings of safety and depressive symptoms during the SARS-CoV-2 pandemic Maria Łuczak, Katarzyna Wszołek, Karolina Chmaj-Wierzchowska, Małgorzata Pięt, Maciej Wilczak
4 [GO] 2024―Apr―20 "LC Risk Score" - development and evaluation of a scale for assessing the risk of developing long COVID Mateusz Babicki, Mateusz Lejawa, Tadeusz Osadnik, Joanna Kapusta, Maciej Banach, Piotr Jankowski, et al. (+4)
5 [GO] 2023―Nov―13 Shared immune metabolic reprogramming between COVID-19 patients in the intensive care unit and ischemic stroke: a pilot study Jie Li, Fushen Li, Bin He, Cong Yu, Ping Zheng
6 [GO] 2023―Sep―22 Evaluation of Selected Factors Influencing Sleep Disorders in Paramedics during the COVID-19 pandemic Kamil Piotr Marczewski, Magdalena Piegza, Natalia Justyna Gospodarczyk, Alicja Zofia Gospodarczyk, Mateusz Marcinek, Michał Tkocz, Krystyn Sosada
7 [GO] 2023―Jun―11 Risk factors of severe course and fatality in children hospitalized for COVID-19 - two centers cohort study. Lidia Stopyra, Aleksandra Kowalik, Łukasz Wentrys, Przemko Kwinta
8 [GO] 2023―Apr―09 The Possibilities of Prospective Assessment of SARS-CoV-2 Infection Risk Based on an Artificial Neural Network Model - A Cross-sectional and In Silico Study. Sylwiusz Niedobylski, Konrad Wachoł, Sara Moqbil, Agata Smoleń, Marcin Lewicki
9 [GO] 2023―Jan―20 The Use of Extracorporeal Membrane Oxygenation in COVID-19: a systematic review Georgiana Ionescu, Marius Andrei Zavalichi, Cătălina Marina Arsenescu Georgescu, Adelina Mihaescu, Simona Daniela Zavalichi, Cristian Statescu, et al. (+4)
10 [GO] 2023―Jan―16 The construction and practice of a standardized nursing service system based on the designated hospital for the treatment of COVID-19 in China Aihong Pan, Yu Zhao, Weihua Yu, Lili Chen, Xufeng Wu, Jing Liu, et al. (+4)
11 [GO] 2023―Jan―16 Cold chain-affiliated associated SARS-CoV-2 omicron BA.2 infections, Qingdao, Shandong, China, 2022 Fanghua Zhang, Rongli Sun, Chengming Qu, Xueyu Ma, Chunling Zhang
12 [GO] 2023―Jan―14 Innovative technology for rapid molecular diagnostics: COVID-19 and other respiratory tract infections Mariusz Gujski, Emilian Snarski, Katarzyna Dzierżanowska-Fangrat, Piotr Hoffman, Wojciech Braksator, Marcin Czech, et al. (+5)
13 [GO] 2022―Nov―07 Relapsed focal segmental glomerulosclerosis and severe acute kidney injury after Oxford-AstraZeneca (AZ) COVID-19 vaccine Yu-Ting Huang, Fu-Pang Chang, Szu-Chun Hung, Yi-chun Wang
14 [GO] 2022―Nov―07 A comparison of the protective effect of vaccination and clinical features between the SARS-CoV-2 wild-type strain and Delta (B.1.617.2) variant Yanzi Li, Zhi Wang, Junhui Liu, Jianfeng Han, Lin Yang
15 [GO] 2022―Oct―28 The effect of the COVID-19 pandemic on pro and advanced cycling athletes: A cross-sectional study in Poland Pawel Rzymski, Piotr Rzymski, Bartlomiej Burzynski, Tomasz Jurys, Michalina Knapik, Izabela Rzymska
16 [GO] 2022―Aug―30 Perspective: repurposed Drugs for COVID-19 Kesara Na-Bangchang, Supattra Porasuphatana, Juntra Karbwang
17 [GO] 2022―Aug―30 A qualitative study of psychological stress among China’s frontline nurses fighting COVID-19 Aihong Pan, Yuyan Wu, Xiaoju Chen, Weihua Yu, Xufeng Wu, Lili Chen, et al. (+3)
18 [GO] 2022―Aug―30 Comparison of antibiotic use in the COVID-19 pandemic with the pre-pandemic period in a university hospital Ilknur Erdem, Enes Ardic, Ece Turker, Muhammed Enes Kardan, Mahluga Javarova Demirkapu
19 [GO] 2022―Aug―03 Outcomes of SARS-CoV-2 infection in patients under treatment with pharmacological immunosuppression. A Swiss cohort study. Antonio Galante, Benedetta Terziroli Beretta-Piccoli, Alberto Pagnamenta, Lorenzo Ruinelli, Massimo Leo, Andrea De Gottardi
20 [GO] 2022―Jun―24 Heterologous high dose SARS-CoV-2 mRNA vaccine booster may improve immune response in seronegative kidney transplant recipients Leszek Tylicki, Bogdan Biedunkiewicz, Zuzanna Ślizień, Marta Muchlado, Alicja Dębska-Ślizień
21 [GO] 2022―Apr―04 SARS-CoV-2 infection activating a novel variant of NOTCH3 Gene and subsequently causing development of Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy (CADASIL) Zbigniew Król, Małgorzata Dorobek, Maciej Dąbrowski, Justyna Zielińska-Turek, Bartosz Mruk, Jerzy Walecki, et al. (+12)
22 [GO] 2022―Apr―04 Does prior SARS-CoV-2 infection increase the risk of adverse effects after mRNA vaccination (BNT162b2) - the retrospective cohort study of physicians. Marcin Hachuła, Michal Kosowski, Eliza Wojciechowska, Mateusz Maliglowka, Marcin Basiak, Boguslaw Okopien
23 [GO] 2022―Feb―26 Biochemical and cardiovascular predictors of PIMS-TS risk in children after COVID-19 recovery: preliminary results of the LATE-COVID-Kids Study Izabela Jatczak-Pawlik, Joanna Lewek, Elżbieta Czkwianianc, Agnieszka Blomberg, Natalia Krysiak, Krzysztof Zeman, et al. (+2)
24 [GO] 2022―Jan―18 COVID-19 research: quality of biostatistics Michal Ordak
25 [GO] 2022―Jan―14 An Individualized Algorithm to Predict Mortality in COVID-19 Pneumonia: a Machine Learning Based Study Maria Elena Laino, Elena Generali, Tobia Tommasini, Giovanni Angelotti, Alessio Aghemo, Antonio Desai, et al. (+5)
26 [GO] 2021―Dec―18 Cost-effectiveness analysis of COVID-19 vaccination in Poland Katarzyna Orlewska, Waldemar Wierzba, Andrzej Śliwczynski
27 [GO] 2021―Dec―07 The impact of the COVID-19 pandemic on urological care in Poland - Post-COVID resilience scenarios and recommendations for healthcare system: A national population-based modelling study. Artur Antoniewicz, Wojciech Niemczyk, Piotr Regulski, Marek Niezgodka
28 [GO] 2021―Nov―10 Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection Marilisa Bove, Federica Fogacci, Silvia Quattrocchi, Maddalena Veronesi, Arrigo Cicero
29 [GO] 2021―Oct―24 Efficacy of early treatment with hydroxychloroquine in people with mild to moderate COVID-19: A systematic review and meta-analysis Adrian Hernandez, John Ingemi III, Michael Sherman, Vinay Pasupuleti, Joshuan Barboza, Alejandro Piscoya, et al. (+2)
30 [GO] 2021―Oct―15 Nanoparticles: breakthrough in COVID-19 prevention, diagnosis and treatment Aleksandra Skwarek, Aleksandra Gąsecka, Miłosz Jaguszewski, Łukasz Szarpak, Tomasz Dzieciątkowski, Krzysztof Filipiak
31 [GO] 2021―Oct―04 SARS-CoV-2 assessment of non-healthcare workers: The potential role of work safety recommendations Bernardo Sousa-Pinto, Rui Costa, Henrique Veiga-Fernandes, Cláudia Dias, António Vidigal, Alípio Araújo, et al. (+8)
32 [GO] 2021―Sep―22 Hypertensive urgencies during the first wave of COVID-19 pandemic in a tertiary hospital setting: A “U” shaped alarming curve. IOANNIS LEONTSINIS, Niki Katsiki, VASILIOS PAPADEMETRIOU, CHRISTINA CHRYSΟHOOU, MARIA KARIORI, IOANNIS DALAKOURAS, et al. (+14)
33 [GO] 2021―Sep―02 A new workflow on bone marrow aspiration and biopsy during the COVID-19 pandemic Hui Xiao, Jing He, Sanyun Wu, Hui Shen, Li Liu, Xiaoyan Liu, et al. (+4)
34 [GO] 2021―Aug―21 COVID-19: Access to Information, Health Service, Daily Life Facility and Risk Perception of Foreigners during Coronavirus pandemic in South Korea Md Nazirul Islam Sarker, Md Lamiur Raihan, Yang Peng, Tahmina Chumky, M M Kamruzzaman, Roger C Shouse, Huh Chang Deog
35 [GO] 2021―Jul―13 Continuing cancer care delivery during the peak of COVID-19 in the Bronx, New York: experience from a public teaching hospital Surabhi Pathak, Roshni Narurkar, Mohammed Hasan Khan, Bei Jiang, May Nyein Chann Soe, Caroline Hwang, et al. (+2)
36 [GO] 2021―Jul―13 Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection José María Hernández Pérez, Juan Marco Figueira Gonçálves, Yolanda Ramallo Fariña
37 [GO] 2021―May―10 Is COVID-19 Another Case of Obesity Paradox? - Results from An International Ecological Study on behalf of the REPROGRAM Consortium Obesity Sonu Bhaskar, Sanja Jovanovic, Anubhav Katyal, Narayanan Namboodiri, Dimitrios Chatzis, Maciej Banach
38 [GO] 2021―May―10 Factors potentially influencing case fatality rate in different stages of COVID-19 outbreak in Europe Katarzyna Orlewska, Pawel Orlewski, Justyna Klusek
39 [GO] 2021―May―08 Diagnostic Accuracy of Antibody-based Rapid Diagnostic Test in Detecting Coronavirus Disease 2019: Systematic Review Yanto Tjang, Tiara Gracienta, Ryan Herardi, Frans Santosa, Taufiq Pasiak
40 [GO] 2021―May―04 Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome Yudi Oktaviono, Eka Mulia, Kevin Luke, David Nugraha, Irma Maghfirah, Agus Subagjo
41 [GO] 2021―May―02 Comparative Analysis of Anxiety/Depression Scores in COVID-19 Patients with Disease Severity, Sleep Patterns, and Certain Laboratory Test Results Zi-Qiang Meng, Qi Leng, Xu Wang, Chun-Hai Xu, Jing Xu, Yan Liu
42 [GO] 2021―Apr―29 Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis Amir Vahedian-Azimi, Seyede Mohammadi, Farshad Beni, Maciej Banach, Paul Guest, Tannaz Jamialahmadi, Amirhossein Sahebkar
43 [GO] 2021―Apr―22 Bioactive lipids-based therapeutic approach to COVID-19 and other similar infections Undurti Das
44 [GO] 2021―Apr―07 Cancer screenings coverage in Poland - from bad to better and to the worst during SARS-CoV-2 pandemic Paweł Koczkodaj, Michał Kamiński, Agata Ciuba, Joanna Didkowska
45 [GO] 2021―Mar―28 Could amantadine possibly interfere with COVID-19 vaccines based on LNP-mRNA platform ? Jaroslaw Fedorowski
46 [GO] 2021―Mar―22 COVID-19 and cardiovascular complications - the preliminary results of the LATE-COVID study Joanna Lewek, Izabela Jatczak-Pawlik, Marek Maciejewski, Piotr Jankowski, Maciej Banach
47 [GO] 2021―Mar―22 Contracting COVID-19 in the First and Second trimester of pregnancy, What We Know- a Concise Qualitative Systematic Review Jasmine Abu-Amara, Dawid Szpecht, Salwan Al-Saad, Lukasz Karbowski
48 [GO] 2021―Mar―22 Clinical characteristics of COVID-19 in young patients differ from middle-aged and elderly patients Keqiang Wan, Chang Su, Lingxi Kong, Juan Liao, Wenguang Tian, Hua Luo
49 [GO] 2021―Mar―22 Big data driven COVID-19 pandemic crisis management: Potential approach for global health Yang Lv, Chenwei Ma, Xiaohan Li, Min Wu
50 [GO] 2021―Mar―22 Longitudinal investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in older patients in the province of Palermo (Southern-Italy) during the early wave of the pandemics Domenica MATRANGA, Laura Maniscalco, Marco Enea, Dario De Luca, Davide Brancato, Emanuele La Spada, et al. (+2)
51 [GO] 2021―Mar―22 Serological Testing for SARS-CoV-2 in Bosnia and Herzegovina: First report Adna Ašić, Jasminka Prguda-Mujić, Lana Salihefendić, Larisa Bešić, Daria Ler
52 [GO] 2021―Mar―22 Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease Piotr Lipiński, Jolanta Zaborniak, Piotr Garnuszek, Przemysław Szurmak
53 [GO] 2021―Mar―22 Identification of Natural Compounds (Proanthocyanidin and Rhapontin) as High-Affinity Inhibitor of SARS-CoV-2 Mpro and PLpro using Computational Strategies Mohamed AlAjmi, Asim Azhar, Sadaf Hasan, Abdullah Alshabr, Afzal Hussain, Md Tabish Rehman
54 [GO] 2021―Mar―22 Genomic Variations in SARS-CoV-2 Strains at the Target Sequences of Nucleic Acid Amplification Tests Canhui Cao, Ruidi Yu, Shaoqing Zeng, Dan Liu, Wenjian Gong, Ruyuan Li, et al. (+10)
55 [GO] 2021―Mar―03 Ethnicity and other COVID-19 death risk factors in Mexico Erwin Chiquete, Jesus Alegre-Díaz, Ana Ochoa-Guzmán, Liz Nicole Toapanta-Yanchapaxi, Carlos González-Carballo, Adrián Garcilazo-Ávila, et al. (+9)
56 [GO] 2021―Mar―03 It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window? Mostafa Ghanei
57 [GO] 2021―Mar―03 Not as black as it is painted? The impact of the first wave of COVID-19 pandemic on surgical treatment of urological cancer patients in Poland - a cross-country experience Piotr Zapała, Aleksander Ślusarczyk, Paweł Rajwa, Mikołaj Przydacz, Wojciech Krajewski, Bartosz Dybowski, et al. (+24)
58 [GO] 2021―Mar―03 Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline Elisabetta Schiaroli, Anna Gidari, Giovanni Brachelente, Sabrina Bastianelli, Alfredo Villa, Carla Ferri, Daniela Francisci
59 [GO] 2021―Mar―03 Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis Alejandro Piscoya, Luis Ng-Sueng, Angela Parra del Riego, Renato Cerna-Viacava, Vinay Pasupuleti, Priyaleela Thota, et al. (+2)
60 [GO] 2020―Sep―16 Significant COVID-19 burden in Polish children Teresa Jackowska, August Wrotek, Mateusz Jankowski, Jarosław Pinkas
61 [GO] 2020―Sep―16 COVID-19 disease: novel clinical manifestations and therapeutic exploration Chun Liu, Qiang Huang, PingXi Wang, HuaPing Wu, ShuKai Deng, Dan Liu, et al. (+4)
62 [GO] 2020―Sep―16 Changing patterns of urologic emergency visits and admissions during the COVID-19 pandemic: a retrospective, multicenter, nationwide study Pawel Rajwa, Mikolaj Przydacz, Wojciech Krajewski, Blazej Kuffel, Piotr Zapala, Aleksandra Krzywon, et al. (+32)
63 [GO] 2020―Sep―16 Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study Jun Fei, Lin Fu, Ying Li, Hui-Xian Xiang, Ying Xiang, Meng-Die Li, et al. (+3)
64 [GO] 2020―Aug―26 COVID-19 in Poland: potential associations with epidemiology, population and healthcare quality Katarzyna Orlewska, Justyna Klusek
65 [GO] 2020―Jul―26 Tocilizumab in severe COVID-19 Nicola Lucio Liberato, Andrea De Monte, Giuseppe Caravella
66 [GO] 2020―Jun―26 Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 - can we end this viral series? Andrei Cosmin Cismaru, Laurentiu Gabriel Cismaru, Seyed Nabavi, Ioana Berindan-Neagoe, Emilio Clementi, Maciej Banach, Seyed Nabavi
67 [GO] 2020―Jun―15 “Celebrating old age”: an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among the elderly Alexandru Burlacu, Ionut Mavrichi, Radu Crisan-Dabija, Daniel Jugrin, Smaranda Buju, Bogdan Artene, Adrian Covic
68 [GO] 2020―May―22 Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces Vanessa Bianconi, Paola Bronzo, Maciej Banach, Amirhossein Sahebkar, Massimo Mannarino, Matteo Pirro
69 [GO] 2020―May―07 Statins and the COVID-19 main protease: in silico evidence on direct interaction Željko Reiner, Mahdi Hatamipour, Maciej Banach, Matteo Pirro, Khalid Al-Rasadi, Tannaz Jamialahmadi, et al. (+3)
70 [GO] 2020―May―07 Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic Niki Katsiki, Maciej Banach, Dimitri Mikhailidis
71 [GO] 2020―May―07 Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 Seyed Nabavi, Solomon Habtemariam, Emilio Clementi, Ioana Berindan-Neagoe, Cosmin Cismaru, Mahsa Rasekhian, et al. (+5)
72 [GO] 2020―May―07 State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2 Sayed Azeez, Zahra Ghalib Alhashim, Waad Mohammed Al Otaibi, Hind Saleh Alsuwat, Abdallah M. Ibrahim, Noor B. Almandil, J. Francis Borgio
73 [GO] 2020―May―07 State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2 J. Francis Borgio, Hind Saleh Alsuwat, Waad Mohammed Al Otaibi, Abdallah M. Ibrahim, Noor Almandil, Lubna Ibrahim Al Asoom, et al. (+3)
 [1] 

73 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec